Vanguard Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-1,554,979
| Closed | -$152M | – | 4217 |
|
|
2015
Q1 | $152M | Buy |
1,554,979
+234,058
| +18% | +$22.8M | 0.01% | 1205 |
|
|
2014
Q4 | $123M | Buy |
1,320,921
+26,900
| +2% | +$2.5M | 0.01% | 1274 |
|
|
2014
Q3 | $89M | Buy |
1,294,021
+53,640
| +4% | +$3.69M | 0.01% | 1438 |
|
|
2014
Q2 | $130M | Buy |
1,240,381
+176,729
| +17% | +$18.5M | 0.01% | 1226 |
|
|
2014
Q1 | $88.3M | Buy |
1,063,652
+108,024
| +11% | +$8.96M | 0.01% | 1436 |
|
|
2013
Q4 | $61.8M | Buy |
955,628
+88,023
| +10% | +$5.7M | 0.01% | 1651 |
|
|
2013
Q3 | $54.9M | Buy |
867,605
+211,365
| +32% | +$13.4M | 0.01% | 1665 |
|
|
2013
Q2 | $27.6M | Buy |
+656,240
| New | +$27.6M | ﹤0.01% | 1949 |
|